Literature DB >> 23232947

Assessing post-stroke behavior in mouse models of focal ischemia.

Mustafa Balkaya1, Jan M Kröber, Andre Rex, Matthias Endres.   

Abstract

Experimental treatment strategies and neuroprotective drugs that showed therapeutic promise in animal models of stroke have failed to produce beneficial effects in human stroke patients. The difficulty in translating preclinical findings to humans represents a major challenge in cerebrovascular research. The reasons behind this translational road block might be explained by a number of factors, including poor quality control in various stages of the research process, the validity of experimental stroke models, and differences in drug administration and pharmacokinetics. Another major difference between animal studies and clinical trials is the choice of end point or outcome measures. Here, we discuss the necessity of poststroke behavioral testing to bridge the gap between clinical and experimental end points. We review established sensory-motor tests for outcome determination after focal ischemia based on the published literature as well as our own personal experience. Selected tests are described in more detail and good laboratory practice standards for behavioral testing are discussed. This review is intended for stroke researchers planning to use behavioral testing in mice.

Entities:  

Mesh:

Year:  2012        PMID: 23232947      PMCID: PMC3587814          DOI: 10.1038/jcbfm.2012.185

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  74 in total

1.  Good laboratory practice: preventing introduction of bias at the bench.

Authors:  Malcolm R Macleod; Marc Fisher; Victoria O'Collins; Emily S Sena; Ulrich Dirnagl; Philip M W Bath; Alistair Buchan; H Bart van der Worp; Richard Traystman; Kazuo Minematsu; Geoffrey A Donnan; David W Howells
Journal:  Stroke       Date:  2008-08-14       Impact factor: 7.914

2.  Behavioral deficits after distal focal cerebral ischemia in mice: Usefulness of adhesive removal test.

Authors:  Thomas Freret; Valentine Bouet; Claire Leconte; Simon Roussel; Laurent Chazalviel; Didier Divoux; Pascale Schumann-Bard; Michel Boulouard
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

3.  Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.

Authors:  Shengbo Ji; Golo Kronenberg; Mustafa Balkaya; Katrin Färber; Karen Gertz; Helmut Kettenmann; Matthias Endres
Journal:  Exp Neurol       Date:  2008-12-25       Impact factor: 5.330

4.  Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice.

Authors:  Ertugrul Kilic; Ulkan Kilic; Marco Bacigaluppi; Zeyun Guo; Nada Ben Abdallah; David P Wolfer; Russel J Reiter; Dirk M Hermann; Claudio L Bassetti
Journal:  J Pineal Res       Date:  2008-02-14       Impact factor: 13.007

Review 5.  Improving outcome after stroke: overcoming the translational roadblock.

Authors:  Matthias Endres; Britta Engelhardt; Jari Koistinaho; Olle Lindvall; Stephen Meairs; Jay P Mohr; Anna Planas; Nancy Rothwell; Markus Schwaninger; Martin E Schwab; Denis Vivien; Tadeusz Wieloch; Ulrich Dirnagl
Journal:  Cerebrovasc Dis       Date:  2008-02-22       Impact factor: 2.762

6.  A comprehensive analysis of gait impairment after experimental stroke and the therapeutic effect of environmental enrichment in rats.

Authors:  Yonggang Wang; Bruno Bontempi; Shwehuey M Hong; Kala Mehta; Philip R Weinstein; Gary M Abrams; Jialing Liu
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

7.  Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse.

Authors:  Adám Dénes; Szilamér Ferenczi; József Halász; Zsuzsanna Környei; Krisztina J Kovács
Journal:  J Cereb Blood Flow Metab       Date:  2008-06-25       Impact factor: 6.200

8.  Neuroprotection in mice by NGP1-01 after transient focal brain ischemia.

Authors:  Jiukuan Hao; Alexander Mdzinarishvili; Thomas J Abbruscato; Jochen Klein; Werner J Geldenhuys; Cornelis J Van der Schyf; Ulrich Bickel
Journal:  Brain Res       Date:  2008-01-29       Impact factor: 3.252

9.  Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia.

Authors:  Xiaoying Wang; Jianxiang Liu; Haihao Zhu; Emiri Tejima; Kiyoshi Tsuji; Yoshihiro Murata; Dmitriy N Atochin; Paul L Huang; Chenggang Zhang; Eng H Lo
Journal:  Stroke       Date:  2008-04-10       Impact factor: 7.914

10.  The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic.

Authors:  Takato Abe; Alexander Kunz; Munehisa Shimamura; Ping Zhou; Josef Anrather; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-23       Impact factor: 6.200

View more
  94 in total

1.  Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke.

Authors:  Ruslan Rust; Lisa Grönnert; Christina Gantner; Alinda Enzler; Geertje Mulders; Rebecca Z Weber; Arthur Siewert; Yanuar D P Limasale; Andrea Meinhardt; Michael A Maurer; Andrea M Sartori; Anna-Sophie Hofer; Carsten Werner; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

2.  Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia.

Authors:  Anja Kahl; Corey J Anderson; Liping Qian; Henning Voss; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-17       Impact factor: 6.200

3.  Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats.

Authors:  Luciele Varaschini Teixeira; Roberto Farina Almeida; Francieli Rohden; Leo Anderson Meira Martins; Poli Mara Spritzer; Diogo Onofre Gomes de Souza
Journal:  Neurochem Res       Date:  2018-05-31       Impact factor: 3.996

4.  Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning.

Authors:  Junbing Wu; Justin Kung; Jie Dong; Lisa Chang; Chengsong Xie; Ahsan Habib; Sarah Hawes; Nannan Yang; Vivian Chen; Zhenhua Liu; Rebekah Evans; Bo Liang; Lixin Sun; Jinhui Ding; Jia Yu; Sara Saez-Atienzar; Beisha Tang; Zayd Khaliq; Da-Ting Lin; Weidong Le; Huaibin Cai
Journal:  Cell Rep       Date:  2019-07-30       Impact factor: 9.423

5.  Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors.

Authors:  Ankur Jindal; Sathyanarayanan Rajagopal; Lucas Winter; Joshua W Miller; Donald W Jacobsen; Jonathan Brigman; Andrea M Allan; Surojit Paul; Ranjana Poddar
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

6.  Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice.

Authors:  Simon H Bayerl; Melina Nieminen-Kelhä; Thomas Broggini; Peter Vajkoczy; Vincent Prinz
Journal:  J Vis Exp       Date:  2016-12-29       Impact factor: 1.355

7.  Silencing the lncRNA Maclpil in pro-inflammatory macrophages attenuates acute experimental ischemic stroke via LCP1 in mice.

Authors:  Yan Wang; Ying Luo; Yang Yao; Yuhua Ji; Liangshu Feng; Fang Du; Xiaoya Zheng; Tao Tao; Xuan Zhai; Yaning Li; Pei Han; Baohui Xu; Heng Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-21       Impact factor: 6.200

8.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

9.  Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK/PGC-1α pathway.

Authors:  Ghorbangol Ashabi; Fariba Khodagholi; Leila Khalaj; Mahdi Goudarzvand; Masoumeh Nasiri
Journal:  Metab Brain Dis       Date:  2014-01-18       Impact factor: 3.584

10.  Involvement of caveolin-1 in neurovascular unit remodeling after stroke: Effects on neovascularization and astrogliosis.

Authors:  Camille Blochet; Lara Buscemi; Tifenn Clément; Sabrina Gehri; Jérôme Badaut; Lorenz Hirt
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.